[Federal Register: June 23, 2009 (Volume 74, Number 119)]
[Notices]               
[Page 29703]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23jn09-58]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): American Recovery and Reinvestment Act (ARRA)-
Section 317 Immunization Program: Strengthening the Evidence Base 
Measuring Effectiveness of Two Dose of Varicella Vaccine, Funding 
Opportunity Announcement (FOA) IP04-11601ARRA09, Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 12 p.m.-2 p.m., July 28, 2009 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of ``ARRA-Section 317 
Immunization Program: Strengthening the Evidence Base Measuring 
Effectiveness of Two Dose of Varicella Vaccine, FOA IP04-
11601ARRA09.''
    For More Information Contact: Wendy Carr, PhD, CDC, 1600 Clifton 
Road, NE., Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498-
2276.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 12, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention.
[FR Doc. E9-14664 Filed 6-22-09; 8:45 am]

BILLING CODE 4163-18-P